Position in LTRN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$13,805
-$18,394 QoQ
Shares Held
10,077
-5.2% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in LTRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. LTRN ranks #447 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in LTRN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,805 | 10,077 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $32,199 | 10,627 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $144,228 | 33,156 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $77,903 | 24,653 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $99,441 | 28,091 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $88,311 | 27,684 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $98,616 | 26,871 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $119,085 | 25,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $224,400 | 25,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $111,100 | 25,958 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $92,070 | 27,000 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $152,280 | 27,000 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $130,410 | 27,000 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $89,639 | 14,841 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $57,360 | 12,000 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $68,805 | 12,050 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $99,642 | 13,936 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $104,617 | 13,110 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $85,828 | 7,677 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $120,362 | 8,244 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $39,291 | 2,166 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $2,110 | 112 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $19,469 | 1,533 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||